Improving antibiotic prescribing in neonatal units: Time to act

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 97, Issue 2, 2012, Pages

  Russell, Alison Bedford ^a   Sharland, Mike ^b   Heath, Paul T ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CLINICAL PRACTICE; HEALTH HAZARD; HUMAN; INCIDENCE; NEWBORN DEATH; NEWBORN INFECTION; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEPSIS; TREATMENT DURATION; TREATMENT RESPONSE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG PRESCRIPTIONS; HUMANS; INFANT, NEWBORN; NURSERIES, HOSPITAL; SEPSIS;

EID: 84858281203     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.120709     Document Type: Review

References (42)

1. Boyce JM, Cookson B, Christiansen K, et al. Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005;5:653-63. (Pubitemid 41383911)
2. Levy SB. Multidrug resistance-a sign of the times. N Engl J Med 1998;338:1376-8.
3. Singh N, Patel KM, Léger MM, et al. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J 2002;21:1029-33. (Pubitemid 35334510)
4. Dessì A, Puddu M, Testa M, et al. Serratia marcescens infections and outbreaks in neonatal intensive care units. J Chemother 2009;21:493-9.
5. Johnson AP, Sharland M, Goodall CM, et al. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 2010;95:781-5.
6. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7. (Pubitemid 34787630)
7. Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010;125:e1031-8.
8. de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000;355:973-8. (Pubitemid 30148263)
9. Clerihew L, Lamagni TL, Brocklehurst P, et al. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed 2006;91:F188-92. (Pubitemid 43667617)
10. Cotten CM, McDonald S, Stoll B, et al.; National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birthweight infants. Pediatrics 2006;118:717-22. (Pubitemid 46085430)
11. Tiskumara R, Fakharee SH, Liu CQ, et al.; Asia-Pacific Neonatal Infections Study. Neonatal infections in Asia. Arch Dis Child Fetal Neonatal Ed 2009;94:F144-8.
12. Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother 2008;61:743-5. (Pubitemid 351321155)
13. Luck S, Torny M, d'Agapeyeff K, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003;361:1953-4. (Pubitemid 36694585)
14. Muller-Pebody B, Johnson AP, Heath PT, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011;96:F4-F8.
15. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011;96:F9-F14.
16. Depani SJ, Ladhani S, Heath PT, et al. The Contribution of Infections to Neonatal Deaths in England and Wales. European Society of Paediatric Infectious Diseases Annual General Meeting, 2010, Abstract.
17. Stoll BJ, Hansen NI, Adams-Chapman I, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65. (Pubitemid 39491920)
18. Isaacs D. Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed 2000;82:F1-2. (Pubitemid 30316474)
19. Webber S, Wilkinson AR, Lindsell D, et al. Neonatal pneumonia. Arch Dis Child 1990;65:207-11. (Pubitemid 20057813)
20. Clark RH, Bloom BT, Spitzer AR, et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006;117:67-74. (Pubitemid 46050521)
21. Metsvaht T, Pisarev H, Ilmoja M-L, et al. Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis. BMC Pediatr 2009, 9:72.
22. Safer Use of Intravenous Gentamicin for Neonates. NPSA/2010/PSA001. 9 February 2010.
23. Stickland MD, Kirkpatrick CM, Begg EJ, et al. An extended interval dosing method for gentamicin in neonates. J Antimicrob Chemother 2001;48:887-93. (Pubitemid 33735326)
24. Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 2006;1:CD005091.
25. Bitner-Glindzicz M, Pembrey M, Duncan A, et al. Prevalence of mitochondrial 1555A->G mutation in European children. N Engl J Med 2009;360:640-2.
26. Vandebona H, Mitchell P, Manwaring N, et al. Prevalence of mitochondrial 1555A->G mutation in adults of European descent. N Engl J Med 2009;360:642-4.
27. Evaluation of Antibiotics (Ciprofloxacin and Fluconazole) for the Treatment of Infections in Preterm and Term Neonates (TINN). Funded Under Seventh Framework Programme. http://cordis.europa.eu/fp7/projects-en.html (accessed 3 June 10).
28. Van Houten MA, Uiterwaal CS, Heesen GJ, et al. Does the empiric use of vancomycin in pediatrics increase the risk for Gram-negative bacteremia? Pediatr Infect Dis J 2001;20:171-7. (Pubitemid 32151940)
29. Kumar Y, Qunibi M, Neal TJ, et al. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001;85:F182-6. (Pubitemid 33701946)
30. Isaacs D, Fraser S, Hogg G, et al. Staphylococcus aureus infections in Australasian neonatal nurseries. Arch Dis Child Fetal Neonatal Ed 2004;89:F331-5. (Pubitemid 38869676)
31. Flidel-Rimon O, Friedman S, Gradstein S, et al. Reduction in multiresistant nosocomial infections in neonates following substitution of ceftazidime with piperacillin/tazobactam in empiric antibiotic therapy. Acta Paediatr 2003;92:1205-7. (Pubitemid 37297103)
32. Tenover FC, Mohammed MJ, Stelling J, et al. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol 2001;39:241-50. (Pubitemid 32059598)
33. International Neonatal Immunotherapy Study (INIS study). http://www.npeu.ox.ac.uk/inis/documents (accessed October 2010).
34. Bedford Russell AR. The role of granulocyte colony-stimulating factor in augmenting human neonatal neutrophil host defence. MD thesis, University of London, 2009:115-19.
35. Cotten CM, Taylor S, Stoll B, et al.; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66.
36. Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG 2006;113:758-65. (Pubitemid 43961734)
37. Heath PT, Nik Yusoff NK, Baker CJ. Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 2003;88:F173-8.
38. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:1319-27.
39. Russell AR, Steer PJ. Antibiotics in preterm labour-the ORACLE speaks. Lancet 2008;372:1276-8.
40. Millar M, Philpott A, Wilks M, et al. Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom. J Clin Microbiol 2008;46:560-7. (Pubitemid 351231302)
41. So AD, Gupta N, Cars O. Tackling antibiotic resistance. BMJ 2010;340:c2071.
42. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis 2008;21:344-9.